FFCP PHASE1:Hg19::chr16:82230037..82230046,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr16:82230037..82230046,+ | |||
|coexpression_cluster_id=C0 | |||
|description=CAGE_peak_at_chr16:82230037..82230046,+ | |||
|id=chr16:82230037..82230046,+ | |||
|ontology_enrichment_celltype=CL:0002057!4.79e-48!42;CL:0000860!1.42e-44!45;CL:0002194!3.87e-30!63;CL:0000576!3.87e-30!63;CL:0000040!3.87e-30!63;CL:0000559!3.87e-30!63;CL:0002009!4.21e-29!65;CL:0000766!3.97e-27!76;CL:0000839!9.11e-27!70;CL:0000557!2.44e-26!71;CL:0000763!3.96e-17!112;CL:0000049!3.96e-17!112;CL:0002087!6.55e-16!119;CL:0000738!2.03e-14!140;CL:0002031!1.88e-13!124;CL:0000037!6.18e-11!172;CL:0000566!6.18e-11!172;CL:0002032!2.59e-10!165;CL:0000837!2.59e-10!165;CL:0000988!4.25e-10!182;CL:0002557!6.20e-07!1 | |||
|ontology_enrichment_celltype_v019=CL:0000860;6.85e-28;33!CL:0002057;6.85e-28;33!CL:0000473;4.92e-21;39!CL:0000234;4.92e-21;39!CL:0000576;1.31e-13;48!CL:0000766;4.82e-10;69!CL:0002327;1.89e-08;4 | |||
|ontology_enrichment_celltype_v019_2=CL:0000860,2.07e-24,42;CL:0002057,2.07e-24,42;CL:0000473,2.08e-21,48;CL:0000234,2.08e-21,48;CL:0002194,3.39e-17,59;CL:0000576,3.39e-17,59;CL:0000040,3.39e-17,59;CL:0000559,3.39e-17,59;CL:0002009,1.19e-16,61;CL:0000839,1.97e-15,66;CL:0000557,3.28e-15,67;CL:0000766,3.45e-14,72;CL:0000763,1.41e-09,108;CL:0000049,1.41e-09,108;CL:0002087,5.23e-09,115;CL:0002031,1.21e-08,120;CL:0002327,1.96e-08,4;CL:0000738,1.20e-07,136 | |||
|ontology_enrichment_development_v019=UBERON:0008425;1.15e-29;1!CL:0002057;1.04e-17;42 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019=DOID:5093;1.89e-08;4!DOID:1612;1.89e-08;4 | |||
|ontology_enrichment_disease_v019_2=DOID:5093,1.96e-08,4;DOID:1612,1.96e-08,4 | |||
|ontology_enrichment_uberon=UBERON:0002371!5.83e-23!80;UBERON:0001474!4.26e-21!86;UBERON:0002390!3.08e-19!102;UBERON:0003061!3.08e-19!102;UBERON:0004765!2.13e-17!101;UBERON:0001434!2.13e-17!101;UBERON:0002193!3.69e-17!112;UBERON:0002405!1.25e-16!115;UBERON:0002204!2.05e-11!167;UBERON:0003081!7.22e-10!216;UBERON:0002363!7.40e-07!1;UBERON:0007647!7.40e-07!1;UBERON:0010115!7.40e-07!1 | |||
|ontology_enrichment_uberon_v019=UBERON:0001911;1.89e-08;4 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002371,1.82e-13,76;UBERON:0001474,1.64e-12,82;UBERON:0004765,1.97e-11,90;UBERON:0002405,4.50e-11,93;UBERON:0002390,1.59e-10,98;UBERON:0003061,1.59e-10,98;UBERON:0001434,2.55e-10,100;UBERON:0002193,1.41e-09,108;UBERON:0001911,1.96e-08,4;UBERON:0005333,1.96e-08,4;UBERON:0008425,1.96e-08,4;UBERON:0005311,1.96e-08,4 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154816123316076,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.309706370895104,0,0,1.18241114944293,1.03423704220986,0.645484683583826,2.70852973188684,0,0,0,0.612167784741805,0.641858054152187,3.83602275479425,0.329851300186716,0,0,0.870627715885752,0,1.86846674698672,0.75374599577023,0,0.868755378820466,0.605399502633369,0.736555271975129,1.58231193720442,0,0.212604299965044,0,0,0,0.16072558669708,0,0.19891667719909,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.270803863765016,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.087834785693126,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.113432183160021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.590789906681404,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.215714200818617,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.200506470303285,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.18532421910392,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.438450885253763,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.0115799999125,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0769502585037971,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.063186579628488,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157204305099666,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.23806443146374,0,0,0,0,0,0,0,0,0.143444410785353,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr16:82230037..82230046,+ | |||
}} |
Latest revision as of 12:47, 25 July 2015
Short description: | p@chr16:82230037..82230046, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr16:82230037..82230046, + |
Coexpression cluster: | C0_CD14_Eosinophils_Neutrophils_Basophils_CD34_immature_Peripheral |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
classical monocyte | 2.07e-24 | 42 |
CD14-positive, CD16-negative classical monocyte | 2.07e-24 | 42 |
defensive cell | 2.08e-21 | 48 |
phagocyte | 2.08e-21 | 48 |
monopoietic cell | 3.39e-17 | 59 |
monocyte | 3.39e-17 | 59 |
monoblast | 3.39e-17 | 59 |
promonocyte | 3.39e-17 | 59 |
macrophage dendritic cell progenitor | 1.19e-16 | 61 |
myeloid lineage restricted progenitor cell | 1.97e-15 | 66 |
granulocyte monocyte progenitor cell | 3.28e-15 | 67 |
myeloid leukocyte | 3.45e-14 | 72 |
myeloid cell | 1.41e-09 | 108 |
common myeloid progenitor | 1.41e-09 | 108 |
nongranular leukocyte | 5.23e-09 | 115 |
hematopoietic lineage restricted progenitor cell | 1.21e-08 | 120 |
mammary gland epithelial cell | 1.96e-08 | 4 |
leukocyte | 1.20e-07 | 136 |
Ontology term | p-value | n |
---|---|---|
bone marrow | 1.82e-13 | 76 |
bone element | 1.64e-12 | 82 |
skeletal element | 1.97e-11 | 90 |
immune system | 4.50e-11 | 93 |
hematopoietic system | 1.59e-10 | 98 |
blood island | 1.59e-10 | 98 |
skeletal system | 2.55e-10 | 100 |
hemolymphoid system | 1.41e-09 | 108 |
mammary gland | 1.96e-08 | 4 |
mammary bud | 1.96e-08 | 4 |
mammary ridge | 1.96e-08 | 4 |
mammary placode | 1.96e-08 | 4 |
Ontology term | p-value | n |
---|---|---|
thoracic cancer | 1.96e-08 | 4 |
breast cancer | 1.96e-08 | 4 |